Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA advisory committee rejects Amphotec supplemental NDA

April 21, 1997

Zagam available in Germany

April 18, 1997

ImmuCell to initiate clinical trial of DiffGAM

April 18, 1997

Morinaga Milk claims new antiparasitic agents

April 18, 1997

Isis receives contract for combinatorial antibacterial drug research

April 16, 1997

Use of desbutylhalofantrine for malaria claimed

April 15, 1997

Tentative approval for Faulding's generic aciclovir for injection

April 14, 1997

University of Michigan researchers describe anti-HCMV agents

April 14, 1997

Encouraging results from preclinical trial of Atlantic's RSV therapy

April 11, 1997

Hybridon selects HPV drug candidate

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...